Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2016)

Neuroone Medical Technologies filings provide 2 years of Liabilities from Discontinued Operations readings, the most recent being 21807.0 for Q4 2016.

  • On a quarterly basis, Liabilities from Discontinued Operations rose 10.02% to 21807.0 in Q4 2016 year-over-year; TTM through Dec 2016 was 21807.0, a 10.02% increase, with the full-year FY2016 number at 21807.0, up 10.02% from a year prior.
  • Liabilities from Discontinued Operations hit 21807.0 in Q4 2016 for Neuroone Medical Technologies, roughly flat from 21807.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 21807.0 in Q2 2016 to a low of 19821.0 in Q4 2015.